 | Up a level |
2022
Borchmann, Peter, Vandenberghe, Peter, Urbano-Ispizua, Alvaro, Haioun, Corinne, Lemonnier, Francois, Griskevicius, Laimonas, Maury, Sebastien, Holtkamp, Silke, Friedrichs, Birte, Zadoyan, Gregor, Hanssens, Linda, Overstijns, Toon, Assenmacher, Mario, Bethke, Ulf, Buerger, Iris, Reer, Olaf, Jaeger, Ulrich and Kersten, Marie Jose (2022). Trial in Progress: A Randomized Phase II Study of MB-CART2019.1 Compared to Standard of Care Therapy in Patients with Relapsed/Refractory DLBCL Ineligible for High-Dose Chemotherapy and Autologous Stem Cell Transplantation- DALY 2-EU Trial. Blood, 140. S. 12784 - 12786. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
2020
Tournilhac, Olivier, van Gelder, Michel, Dreger, Peter, Bornhaeuser, Martin, Platzbecker, Uwe, Scheid, Christof, Beelen, Dietrich, Jindra, Pavel, Cornelissen, Jan J., Sengeloev, Henrik, Nguyen, Stephanie, Mayer, Jiri, Stelljes, Matthias, Dilhuydy, Marie-Sarah, Griskevicius, Laimonas, Vitek, Antonin, Nikolousis, Manos, Kroeger, Nicolaus, Hellmann, Andrzej, Santarone, Stella, Zinger, Nienke, Hayden, Patrick and Yakoub-Agha, Ibrahim (2020). The 10-years EBMT Landscape of Allogeneic Hematopoietic Cell Transplantation (Allohct) for Chronic Lymphocytic Leukemia. Bone Marrow Transplant., 55 (SUPPL 1). S. 60 - 61. LONDON: SPRINGERNATURE. ISSN 1476-5365